2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Authors:
- François MachFMFrançois Mach
- Colin BaigentCBColin Baigent
- Alberico L CatapanoACAlberico L Catapano
- Konstantinos C KoskinasKKKonstantinos C Koskinas
- Manuela CasulaMCManuela Casula
- Lina BadimonLBLina Badimon
- M John ChapmanMCM John Chapman
- Guy G De BackerGBGuy G De Backer
- Victoria DelgadoVDVictoria Delgado
- Brian A FerenceBFBrian A Ference
- Ian M GrahamIGIan M Graham
- Alison HallidayAHAlison Halliday
Top Cited Papers
- 31 August 2019
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (1) , 111-188
Abstract
No abstract availableThis publication has 593 references indexed in Scilit:
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin TherapyJAMA, 2011
- Statins and All-Cause Mortality in High-Risk Primary PreventionArchives of internal medicine (1960), 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJAMA, 2009
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart DiseaseArchives of internal medicine (1960), 2009
- Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk FactorsArchives of internal medicine (1960), 2006
- Knowledge and Attitudes Regarding Cardiovascular Disease Risk and Prevention in Patients With Coronary or Peripheral Arterial DiseaseArchives of internal medicine (1960), 2003
- The Lipid Research Clinics Coronary Primary Prevention TrialArchives of internal medicine (1960), 1992
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984